Schroder Investment Management Group’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-151,608
| Closed | -$534K | – | 1383 |
|
|
2022
Q1 | $534K | Sell |
151,608
-9,565
| -6% | -$33.7K | ﹤0.01% | 1212 |
|
|
2021
Q4 | $1.07M | Buy |
161,173
+5,037
| +3% | +$33.5K | ﹤0.01% | 1021 |
|
|
2021
Q3 | $1.56M | Sell |
156,136
-7,619
| -5% | -$76K | ﹤0.01% | 1025 |
|
|
2021
Q2 | $5.06M | Buy |
163,755
+59,258
| +57% | +$1.83M | 0.01% | 826 |
|
|
2021
Q1 | $4.56M | Sell |
104,497
-11,540
| -10% | -$503K | 0.01% | 838 |
|
|
2020
Q4 | $5.38M | Buy |
+116,037
| New | +$5.38M | 0.01% | 786 |
|